These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 17154097)
1. [Childhood Graves' disease]. Sasaki N; Sato K Nihon Rinsho; 2006 Dec; 64(12):2308-11. PubMed ID: 17154097 [TBL] [Abstract][Full Text] [Related]
2. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy. Laurberg P; Berman DC; Andersen S; Bülow Pedersen I Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677 [TBL] [Abstract][Full Text] [Related]
3. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism. He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329 [TBL] [Abstract][Full Text] [Related]
4. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism. Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139 [TBL] [Abstract][Full Text] [Related]
5. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU). Kubota S Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063 [TBL] [Abstract][Full Text] [Related]
6. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease. Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243 [TBL] [Abstract][Full Text] [Related]
7. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704 [TBL] [Abstract][Full Text] [Related]
8. Treatment outcome of Graves' disease in Thai children. Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924 [TBL] [Abstract][Full Text] [Related]
9. Graves' disease in children and adolescents: response to long-term treatment. Barrio R; López-Capapé M; Martinez-Badás I; Carrillo A; Moreno JC; Alonso M Acta Paediatr; 2005 Nov; 94(11):1583-9. PubMed ID: 16303698 [TBL] [Abstract][Full Text] [Related]
11. Persistent remission of Graves` disease or evolution from Graves' disease to Hashimoto's thyroiditis in childhood - a report of 6 cases and clinical implications. Smyczńyska J; Cyniak-Magierska A; Stasiak M; Karbownik-Lewińska M; Lewiński A Neuro Endocrinol Lett; 2014; 35(5):335-41. PubMed ID: 25275265 [TBL] [Abstract][Full Text] [Related]
12. Severe pancytopenia associated with antithyroid drugs in a patient with Graves' disease and chronic renal failure. Macia M; Méndez M; Fernández J; Riverol A; Rios Clin Nephrol; 1997 Feb; 47(2):129. PubMed ID: 9049463 [No Abstract] [Full Text] [Related]
13. Effect of antithyroid drugs on the occurrence of antibodies against type 2 deiodinase (DIO2), which are involved in hyperthyroid Graves' disease influencing the therapeutic efficacy. Molnár I; Szentmiklósi JA; Gesztelyi R; Somogyiné-Vári É Clin Exp Med; 2019 May; 19(2):245-254. PubMed ID: 30610492 [TBL] [Abstract][Full Text] [Related]
14. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine. Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711 [TBL] [Abstract][Full Text] [Related]
15. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis. Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492 [TBL] [Abstract][Full Text] [Related]
16. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil. Momotani N; Yamashita R; Makino F; Noh JY; Ishikawa N; Ito K Clin Endocrinol (Oxf); 2000 Aug; 53(2):177-81. PubMed ID: 10931098 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism. Homsanit M; Sriussadaporn S; Vannasaeng S; Peerapatdit T; Nitiyanant W; Vichayanrat A Clin Endocrinol (Oxf); 2001 Mar; 54(3):385-90. PubMed ID: 11298092 [TBL] [Abstract][Full Text] [Related]
18. [Current problems in the treatment of Graves' disease in pregnancy and in lactation]. Momotani N Nihon Rinsho; 2006 Dec; 64(12):2297-302. PubMed ID: 17154095 [TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity and cutaneous reactions after antithyroid drug administration. Otsuka F; Noh JY; Chino T; Shimizu T; Mukasa K; Ito K; Ito K; Taniyama M Clin Endocrinol (Oxf); 2012 Aug; 77(2):310-5. PubMed ID: 22332800 [TBL] [Abstract][Full Text] [Related]
20. Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease. Santos RB; Romaldini JH; Ward LS Thyroid; 2004 Jul; 14(7):525-30. PubMed ID: 15307942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]